Nancyclotep is positioning.

itself to become the reference center for vectorized internal radiotherapy in the Greater East region

 
 

Nancyclotep develops and offers solutions

ranging from R&D to clinical studies and production

 
 

Nancyclotep in numbers

►► Over 100 clinical studies ►► Over 60,000 PET exams since the installation of the first tomograph in 2002 ►► Over 55 preclinical small animal studies

1
1

Founded in 2007, Nancyclotep develops and offers solutions ranging from R&D to clinical studies and production, enabling to meet the needs for the transfer of radiopharmaceuticals to the clinical setting.

Nancyclotep features state-of-the-art facilities including a radiochemistry and radiopharmacy laboratory, a preclinical studies platform, an industrial production laboratory, 3 PET-scans, an e-learning laboratory offering innovative solutions and a hospital environment enabling immediate access to both medical competencies and patients for clinically useful technological applications.

Nancyclotep is a public-private Economic Interest Group, located on the site of the University Hospital (CHRU) of Nancy (France) and employs 18 people.

Activities

Radiochemistry

Preclinical research

Clinical research

Radiopharmacy

Image processing

E-learning

Nancyclotep in numbers

Approximately 18 people work full-time for Nancyclotep, which brings together on the same site a myriad of professions and skills: chemists, radiochemists, hospital and industrial pharmacists, physicians, biologists, technicians, computer scientists, electroradiology technicians, secretaries, etc.

100

clinical studies

60000

PET exams since the installation of the first tomograph in 2002

55

preclinical small animal studies